Lunyi Lao

Array ( [id] => 6749890 [patent_doc_number] => 20030044410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Treatment of autoimmune diseases including AIDS' [patent_app_type] => new [patent_app_number] => 10/150642 [patent_app_country] => US [patent_app_date] => 2002-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16700 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044410.pdf [firstpage_image] =>[orig_patent_app_number] => 10150642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986078 [patent_doc_number] => 20020098581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor' [patent_app_type] => new [patent_app_number] => 10/027892 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11423 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098581.pdf [firstpage_image] =>[orig_patent_app_number] => 10027892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603490 [patent_doc_number] => 20020015701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Process for inhibiting complement activation via the alternative pathway' [patent_app_type] => new [patent_app_number] => 09/976649 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16417 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015701.pdf [firstpage_image] =>[orig_patent_app_number] => 09976649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889192 [patent_doc_number] => 20010024647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Conformation-specific anti-von Willebrand factor antibodies' [patent_app_type] => new [patent_app_number] => 09/823748 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2619 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20010024647.pdf [firstpage_image] =>[orig_patent_app_number] => 09823748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901483 [patent_doc_number] => 20010023066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'Methods of screening for or treating cancers or autoimmune disorders in which a complement C3 or C3 related protein is associated' [patent_app_type] => new [patent_app_number] => 09/799952 [patent_app_country] => US [patent_app_date] => 2001-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17156 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20010023066.pdf [firstpage_image] =>[orig_patent_app_number] => 09799952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6879978 [patent_doc_number] => 20010031264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Vaccine compositions and methods of modulating immune responses' [patent_app_type] => new [patent_app_number] => 09/789922 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031264.pdf [firstpage_image] =>[orig_patent_app_number] => 09789922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901659 [patent_doc_number] => 20010023242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'Anti-tumor agent comprising salmosin as an active ingredient' [patent_app_type] => new [patent_app_number] => 09/776268 [patent_app_country] => US [patent_app_date] => 2001-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5038 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20010023242.pdf [firstpage_image] =>[orig_patent_app_number] => 09776268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967331 [patent_doc_number] => 20020090370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Novel porcine protein and uses thereof' [patent_app_type] => new [patent_app_number] => 09/753007 [patent_app_country] => US [patent_app_date] => 2001-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9342 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090370.pdf [firstpage_image] =>[orig_patent_app_number] => 09753007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7013988 [patent_doc_number] => 20010051159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12' [patent_app_type] => new [patent_app_number] => 09/732502 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11256 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051159.pdf [firstpage_image] =>[orig_patent_app_number] => 09732502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508399 [patent_doc_number] => 06441137 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Expressed ligand-vascular intercellular signalling molecule' [patent_app_type] => B1 [patent_app_number] => 09/709188 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 54 [patent_no_of_words] => 48734 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441137.pdf [firstpage_image] =>[orig_patent_app_number] => 09709188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1320436 [patent_doc_number] => 06605711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'NY-ESO-1 peptide derivatives, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/676005 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10087 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605711.pdf [firstpage_image] =>[orig_patent_app_number] => 09676005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422094 [patent_doc_number] => 06506875 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Isolated peptides which bind to HLA-C molecules and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/670456 [patent_app_country] => US [patent_app_date] => 2000-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6699 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506875.pdf [firstpage_image] =>[orig_patent_app_number] => 09670456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440526 [patent_doc_number] => 06335013 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Methods and materials relating to CD39-like polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/608285 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 54263 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335013.pdf [firstpage_image] =>[orig_patent_app_number] => 09608285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476709 [patent_doc_number] => 06451314 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'MHC conjugates useful in ameliorating autoimmunity' [patent_app_type] => B1 [patent_app_number] => 09/602807 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 22816 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451314.pdf [firstpage_image] =>[orig_patent_app_number] => 09602807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1206351 [patent_doc_number] => 06716974 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-06 [patent_title] => 'Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/579536 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 51735 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716974.pdf [firstpage_image] =>[orig_patent_app_number] => 09579536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4270248 [patent_doc_number] => 06280743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Use of mCRP to enhance immune responses' [patent_app_type] => 1 [patent_app_number] => 9/568212 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7674 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280743.pdf [firstpage_image] =>[orig_patent_app_number] => 568212 [rel_patent_id] =>[rel_patent_doc_number] =>)